CompletedNot Applicable

Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry Eye

Israel29 participantsStarted 2017-11-01

Plain-language summary

The study aims to test the safety of Repetitive Magnetic Stimulation (RMS) treatment for dry eye disease. Patients are asked to undergo a one-time treatment with Epitech Ocular Magnetic Stimulation Device on one eye in the first stage and both eyes sequentially in the second stage of the study. Changes are monitored for over a study period of 3 months.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Males and females, 18-80 years old
✓. Subjects with moderate to severe dry eye syndrome
✓. Subjects able to understand the requirements of the protocol and provide informed consent.

Exclusion criteria

✕. Eyes with other ocular surface pathology which requires more treatment than eye lubricant and conventional eyelid hygiene
✕. A concurrent ocular disease including ocular infection or pterygium.
✕. Ocular surgery within the previous 6 months and LASIK within the previous 1 year.
✕. Any ocular injury or ocular Herpes infection within past 3 months
✕. Anticipated necessity to wear contact lens in the duration of the study.
✕. Unstable thyroid disorders (Drugs Tx not stable in the last 3 months).
✕. Alcoholism
✕. Pregnant or nursing women

What they're measuring

Best Corrected Visual Acuity (BCVA)

Timeframe: 3 mounth

Trial details

NCT IDNCT03012698

SponsorEpitech Mag Ltd.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2019-06-17

View on ClinicalTrials.gov More Dry Eye trials